Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00425230 · ClinicalTrials.gov registry record · NA
Open Label Study of Duloxetine for the Treatment of Phantom Limb Pain
A NA study, sponsored by Baylor College of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT00425230 is a NA study that was terminated before completion, run by Baylor College of Medicine. The registered enrollment target is 15 participants.
The verdict
NCT00425230, a NA study, was terminated before completion, sponsored by Baylor College of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This is a study to assess the possible benefit of duloxetine in the treatment of chronic phantom limb pain.
Interventions
- DRUG Duloxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2007-01 |
| Est. Completion | 2007-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00425230
The ClinicalTrials.gov registry entry for NCT00425230 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Duloxetine is the first listed.
NCT00425230 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00425230 about?
NCT00425230 is a clinical study titled "Open Label Study of Duloxetine for the Treatment of Phantom Limb Pain". This is a study to assess the possible benefit of duloxetine in the treatment of chronic phantom limb pain.
What is the current status of trial NCT00425230?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2007-01. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00425230?
The interventions under investigation include: Duloxetine (DRUG).
Who is sponsoring clinical trial NCT00425230?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.